UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apoptosis: Activate NF-κB or die?

Current biology, 1997-02, Vol.7 (2), p.R94-R96

1997

Volltextzugriff (PDF)

Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression

Molecular and Cellular Biology, 1994-09, Vol.14 (9), p.5820-5831

1994

Volltextzugriff (PDF)

The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels

Journal of Virology, 1989-06, Vol.63 (6), p.2469-2475

1989

Volltextzugriff (PDF)

NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules

Advances in immunology, 1997, Vol.65, p.111-137

1997

Volltextzugriff (PDF)

Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus

Oncogene, 1988-05, Vol.2 (5), p.461-468

1988

Volltextzugriff (PDF)

Induction of the Gene Encoding Mucosal Vascular Addressin Cell Adhesion Molecule 1 by Tumor Necrosis Factor α is Mediated by NF-κB Proteins

Proceedings of the National Academy of Sciences - PNAS, 1995-04, Vol.92 (8), p.3561-3565

1995

Volltextzugriff (PDF)

v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor

Nature (London), 1991-07, Vol.352 (6331), p.165-168

1991

Volltextzugriff (PDF)

Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus

Journal of Virology, 1987-03, Vol.61 (3), p.866-875

1987

Volltextzugriff (PDF)

Identification of ERF-1 as a Member of the AP2 Transcription Factor Family

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (9), p.4342-4347

1997

Volltextzugriff (PDF)

The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation

Oncogene, 1989-01, Vol.4 (1), p.67-74

1989

Volltextzugriff (PDF)

The cell-type-specific activator region of c-jun juxtaposes constitutive and negatively regulated domains

Genes & development, 1992-08, Vol.6 (8), p.1493-1502

1992

Volltextzugriff (PDF)

Systematic Mutational Analysis of the Death Domain of the Tumor Necrosis Factor Receptor 1-associated Protein TRADD (∗)

The Journal of biological chemistry, 1996-04, Vol.271 (16), p.9858-9862

1996

Volltextzugriff (PDF)

Sp1 Is a Component of the Cytokine-inducible Enhancer in the Promoter of Vascular Cell Adhesion Molecule-1

The Journal of biological chemistry, 1995-12, Vol.270 (48), p.28903-28909

1995

Volltextzugriff (PDF)

Activity of the cancer metabolism inhibitor MPC-9528 in xenograft models: Comparison of different dosing schedules

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10529-10529

2011

Volltextzugriff (PDF)

Comparison of MPC-6827 activity in xenograft models with different dosing schedules

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13080-e13080

2011

Volltextzugriff (PDF)

Characterization of the BNLF-1 oncogene of Epstein-Barr virus

Current topics in microbiology and immunology, 1989, Vol.144, p.233

1989

Volltextzugriff (PDF)

Transcription factor based therapeutics: drugs of the future?

Trends in biotechnology (Regular ed.), 1993, Vol.11 (1), p.11-18

1993

Volltextzugriff (PDF)

Latency comes of age for herpesviruses

Cell, 1988-03, Vol.52 (6), p.787-789

1988

Volltextzugriff (PDF)

Activate NF-kappa B or die?

Current biology, 1997-02, Vol.7 (2), p.R94

1997

Volltextzugriff (PDF)

Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: Differences between v- and c-Jun

Cell, 1990-11, Vol.63 (4), p.815-825

1990

Volltextzugriff (PDF)

Leucine biosynthesis in yeast: identification of two genes (LEU4, LEU5) that affect α-isopropylmalate synthase activity and evidence that LEU1 and LEU2 gene expression is controlled by α-isopropylmalate and the product of a regulatory gene

Current genetics, 1983-09, Vol.7 (5), p.369-377

1983

Volltextzugriff (PDF)

P172 Spatial Transcriptomics Characterization of S1P Pathway Genes in Ulcerative Colitis and Crohn’s Disease Colon Tissues

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i478-i478

2024

Volltextzugriff (PDF)

Novel antineoplastic agents with efficacy against multidrug resistant tumor cells

Bioorganic & medicinal chemistry letters, 1998-10, Vol.8 (19), p.2653-2656

1998

Volltextzugriff (PDF)

150 POSTER MPC-3100: A non-natural product Hsp90 inhibitor with anti-tumor activity in pre-clinical models

European journal of cancer supplements, 2008, Vol.6 (12), p.48-48

2008

Volltextzugriff (PDF)

Stawamycin, a new pyrroloketoindane natural product from the cultures of Streptomyces sp

Tetrahedron letters, 1995, Vol.36 (32), p.5699-5702

1995

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(7)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Apoptosis: Activate NF-κB or die?

Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression

The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels

NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules

Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus

Induction of the Gene Encoding Mucosal Vascular Addressin Cell Adhesion Molecule 1 by Tumor Necrosis Factor α is Mediated by NF-κB Proteins

v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor

Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus

Identification of ERF-1 as a Member of the AP2 Transcription Factor Family

The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation

The cell-type-specific activator region of c-jun juxtaposes constitutive and negatively regulated domains

Systematic Mutational Analysis of the Death Domain of the Tumor Necrosis Factor Receptor 1-associated Protein TRADD (∗)

Sp1 Is a Component of the Cytokine-inducible Enhancer in the Promoter of Vascular Cell Adhesion Molecule-1

Activity of the cancer metabolism inhibitor MPC-9528 in xenograft models: Comparison of different dosing schedules

Comparison of MPC-6827 activity in xenograft models with different dosing schedules

Characterization of the BNLF-1 oncogene of Epstein-Barr virus

Transcription factor based therapeutics: drugs of the future?

Latency comes of age for herpesviruses

Activate NF-kappa B or die?

Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: Differences between v- and c-Jun

Leucine biosynthesis in yeast: identification of two genes (LEU4, LEU5) that affect α-isopropylmalate synthase activity and evidence that LEU1 and LEU2 gene expression is controlled by α-isopropylmalate and the product of a regulatory gene

P172 Spatial Transcriptomics Characterization of S1P Pathway Genes in Ulcerative Colitis and Crohn’s Disease Colon Tissues

Novel antineoplastic agents with efficacy against multidrug resistant tumor cells

150 POSTER MPC-3100: A non-natural product Hsp90 inhibitor with anti-tumor activity in pre-clinical models

Stawamycin, a new pyrroloketoindane natural product from the cultures of Streptomyces sp

Suchergebnisse filtern